Scholarlink

Background <p>In Colombia, lower respiratory tract infections (LRTI) are one of the main events of interest to public health. This study aims to describe and quantify the direct medical costs associated with hospital care for LRTI in the Colombian health system.</p> Methods <p>A retrospective observational study using hospital and national databases was conducted to analyze the direct hospital costs of patients with LRTI from the perspective of the Colombian healthcare system. Data was obtained from hospital records and the Individual Registry of Health Services Provision (RIPS). Cost assessment was performed using national databases (Sufficiency for Health Benefits and the Drug Price Information System - SISMED). Costs were classified as follows: consultations, laboratory and imaging costs, procedures, medications, supplies, and hospital stay, segmented by age groups and diagnostic subgroups. The analysis used measures of central tendency and dispersion.</p> Results <p>The services of 601 patients from a university hospital and 14,979 hospitalization cases registered in RIPS were analyzed. The findings revealed that costs are concentrated primarily in the population over 60 years of age, especially in treating influenza and pneumonia (J09-J18), accounting for more than 70% of the total cost. According to RIPS, the mean cost per hospitalized patient with LRTI was Int$5,657. At the university hospital, the median cost per patient was Int$7,525 (IQR Int$14,346). Medications and hospital stays were the largest components of the total cost. Additionally, respiratory syncytial virus (RSV) cases had mean hospital costs per patient of Int$7,340, with medications and hospital stays being the main cost drivers.</p> Conclusion <p>The significant economic burden of LRTI on the Colombian health system, especially among adults over 60 years of age, highlights the need to strengthen public health policies aimed at their prevention and control. It is recommended to emphasize vaccination strategies, optimization of hospital management, and strengthening epidemiological surveillance.</p> Clinical trial number <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

How much do lower respiratory tract infections in adults cost? A hospital-based cost analysis in Colombia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月7日

查看全文
  • Paula Andrea Castro García,
  • Luisa Fernanda Moyano Ariza,
  • Esteban Orlando Vanegas Duarte,
  • Juliana Quintero Espinosa,
  • Angela Patricia Aguirre Rodríguez,
  • Darío Londoño Trujillo

摘要

Background

In Colombia, lower respiratory tract infections (LRTI) are one of the main events of interest to public health. This study aims to describe and quantify the direct medical costs associated with hospital care for LRTI in the Colombian health system.

Methods

A retrospective observational study using hospital and national databases was conducted to analyze the direct hospital costs of patients with LRTI from the perspective of the Colombian healthcare system. Data was obtained from hospital records and the Individual Registry of Health Services Provision (RIPS). Cost assessment was performed using national databases (Sufficiency for Health Benefits and the Drug Price Information System - SISMED). Costs were classified as follows: consultations, laboratory and imaging costs, procedures, medications, supplies, and hospital stay, segmented by age groups and diagnostic subgroups. The analysis used measures of central tendency and dispersion.

Results

The services of 601 patients from a university hospital and 14,979 hospitalization cases registered in RIPS were analyzed. The findings revealed that costs are concentrated primarily in the population over 60 years of age, especially in treating influenza and pneumonia (J09-J18), accounting for more than 70% of the total cost. According to RIPS, the mean cost per hospitalized patient with LRTI was Int$5,657. At the university hospital, the median cost per patient was Int$7,525 (IQR Int$14,346). Medications and hospital stays were the largest components of the total cost. Additionally, respiratory syncytial virus (RSV) cases had mean hospital costs per patient of Int$7,340, with medications and hospital stays being the main cost drivers.

Conclusion

The significant economic burden of LRTI on the Colombian health system, especially among adults over 60 years of age, highlights the need to strengthen public health policies aimed at their prevention and control. It is recommended to emphasize vaccination strategies, optimization of hospital management, and strengthening epidemiological surveillance.

Clinical trial number

Not applicable.